These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cyclosporine A in rheumatoid arthritis: randomized, placebo controlled dose finding study. Altman RD, Schiff M, Kopp EJ. J Rheumatol; 1999 Oct; 26(10):2102-9. PubMed ID: 10529124 [Abstract] [Full Text] [Related]
6. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Førre O. Arthritis Rheum; 1994 Oct; 37(10):1506-12. PubMed ID: 7945477 [Abstract] [Full Text] [Related]
7. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Stein CM, Pincus T, Yocum D, Tugwell P, Wells G, Gluck O, Kraag G, Torley H, Tesser J, McKendry R, Brooks RH. Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420 [Abstract] [Full Text] [Related]
10. Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss. van den Borne BE, Landewé RB, Goei The HS, Breedveld FC, Dijkmans BA. Rheumatology (Oxford); 1999 Mar; 38(3):254-9. PubMed ID: 10325664 [Abstract] [Full Text] [Related]
11. The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry. Marra CA, Esdaile JM, Guh D, Fisher JH, Chalmers A, Anis AH. Arthritis Rheum; 2001 Jun; 45(3):240-5. PubMed ID: 11409664 [Abstract] [Full Text] [Related]
12. A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. Ahern MJ, Harrison W, Hollingsworth P, Bradley J, Laing B, Bayliss C. Aust N Z J Med; 1991 Dec; 21(6):844-9. PubMed ID: 1818543 [Abstract] [Full Text] [Related]
13. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Drosos AA, Voulgari PV, Papadopoulos IA, Politi EN, Georgiou PE, Zikou AK. Clin Exp Rheumatol; 1998 Dec; 16(6):695-701. PubMed ID: 9844762 [Abstract] [Full Text] [Related]
14. Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis. Landewe RB, Goei The HS, van Rijthoven AW, Rietveld JR, Breedveld FC, Dijkmans BA. J Rheumatol; 1994 Sep; 21(9):1631-6. PubMed ID: 7799340 [Abstract] [Full Text] [Related]
17. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, Pødenphant J, Hansen G, Lindegaard H, de Carvalho A, Østergaard M, Hørslev-Petersen K, CIMESTRA Study Group. Arthritis Rheum; 2006 May; 54(5):1401-9. PubMed ID: 16645967 [Abstract] [Full Text] [Related]